Purpose: Limitations of Kellgen-Lawrence (KL) grading in osteoarthritis (OA) trials include inconsistent interpretation leading to study population heterogeneity. Knees with radiographic 2-4 mm medial joint space width (mJSW) showed improved responsiveness for radiographic JSW, MRI cartilage thickness and MRI bone area OA biomarkers over 12 months (Bowes et al. EULAR 2017). This criterion was applied post-hoc to data from a phase 2 trial of SM04690, a small molecule Wnt pathway inhibitor in development as a potential disease modifying drug in knee OA (DMOAD).
